The following post is from Federal Agency Weekly. It tracks federal grants policy issuances, rulemakings, guidance development and OIG reports and publications. The primary focus of Federal Agency Weekly is agency-wide grants management issues related to extramural research grants from NIH, NSF, NASA, and DOD, though broader coverage of NIH is provided with the inclusion of NIH program activities.

July 20-July 24, 2020

Discover Grants Management Webinars from Thompson Grants See upcoming schedule ›

National Institutes of Health

• Useful Flexibilities for Animal Care and Use Programs to Comply with the PHS Policy During the COVID-19 Pandemic (by Mike Lauer)
  
  
• New Vertebrate Animals Section (VAS) Online Training Module Available
  
  
• eRA Information: Use of ASSIST Expanded for Submission of Administrative Supplements 
  
  
• OLAW Quarterly Webinar on Sept. 10:“Update on the AVMA Guidelines for the Euthanasia of Animals: 2020 Edition
  
  
• 7/23/20 FR: Information Collection; Proposals, Submissions, and Approvals: Chimpanzee Research Use Form (Office of the Director)
  
  
• Policy Notices
  
  
• NOT-HS-20-012: AHRQ Grant Recipient use of the eRA Commons to Submit First-Time No-Cost Extension (NCE) Notifications for Grant Awards that are under Expanded Authorities
  
  
• NOT-HS-20-012: Notice to Extend PA-17-246
  
  
• General Notices
  
  
• NOT-HG-20-052: Notice of Pre-Application Webinar for Developmental Genotype-Tissue Expression Project (dGTEx)
  
  
• NOT-OD-20-145: Request for Information (RFI) on Flexibilities for Conducting Semiannual Animal Facility Inspections
  
  
• Changes to Funding Opportunities
  
  
• NOT-CA-20-087: Notice of Change to Key Dates and Post Submission Materials Guideline in RFA-CA-20-033, “SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)”
  
  
• NOT-CA-20-088: Notice of Change to Award Information in PAR-19-242, Paul Calabresi Career Development for Clinical Oncology (K12 Clinical Trial Optional)
  
  
• NOT-DA-20-066: Notice of Correction to PAR-20-221, “NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)”
  
  
• NOT-GM-20-038: Notice of Change to the Application Instructions for the Candidate Eligibility Statement in PAR-19-343 “Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)”
  
  
• NOT-GM-20-042: Notice to Reduce the Number of Research Projects Required in PAR-19-313 “Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)”
  
  
• NOT-GM-20-043: Notice to Reduce the Number of Research Projects Required in PAR-19-312 “Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)”
  
  
• NOT-OD-20-142: Notice of Change: Extension to end date for NOT-OD-20-130 RFI: Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models
  
  
• NOT-OD-20-148: Notice of Change: Clarification of Budget for PA-20-227 “Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)”
  
  
• Requests for Proposal
  
  
• NOT-HL-20-798: Request for Proposal (RFP) Notice: NHLBI Progenitor Cell Translational Consortium (PCTC) – Scientific Services to Conduct In-depth Cell Characterization for the NIH Regenerative Medicine Innovation Project 2020
  
  
• Notices of Special Interest
  
  
• NOT-AG-20-039: Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD)
  
  
• NOT-DK-20-036: Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children
  
  

Other HHS Agencies and Offices

• 7/22/20 FR: Guidance: Elimination of Institutional Review Board Review of Research Applications and Proposals; 2018 Requirements
  
  
• 7/24/20 FR: Findings of Research Misconduct (ORI)
  
  

National Science Foundation

• FAQs on NSF’s Implementation of OMB Memorandum M-20-26: Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations
  
  
• NSF Establishes Three New Institutes to Address Critical Challenges in Quantum Information Science
  
  
• News Release: White House Announces New Appointees to the National Science Board
  
  
• NSF INCLUDES Report to the Nation II
  
  
• Statement of the National Science Board on Racism in Science & Engineering
  
  
• Research.gov Unavailable from 10:00 PM ET Friday, July 24th, until 8:00 AM ET Saturday, July 25th.
  
  
• FastLane Unavailable from 8:00 PM ET Friday, July 24th, until 8:00 AM ET Saturday, July 25th
  
  
• CAREER Proposers: NSF has extended the CAREER proposal deadline to 8/11 but strongly encourages proposal submission by 7/27 per the revised CAREER Proposal Submission Timeline.
  
  

NASA

• [none posted]
  
  

Department of Defense

• [none posted]
  
  

Office of Management and Budget

• [none posted]
  
  

Grants.gov

• [none posted]
  
  

Miscellaneous Agencies and Offices

• EPA Frequent Questions on Grant Issues in Response to the Novel Coronavirus (COVID-19) Public Health Emergency
  
  
• Energy Department Announces Approximately $64M in Funding for 18 Projects to Advance H2@Scale
  
  
• Secretary Dan Brouillette and Under Secretary for Science Paul Dabbar to Make Quantum Announcement at the University of Chicago
  
  
• Department of Energy Announces $12 Million for Particle Accelerators for Science & Society

Copyright © 2020 by Thompson Grants, a division of Columbia Books & Information Services, Inc.
All rights reserved.